E. Yu. Shchelkanova

E. Yu. Shchelkanova

Auto-generated profile, based on publicly available information

E. Yu. Shchelkanova

Russian Anti-Plague Institute “Microbe” of the Rospotrebnadzor, Saratov, Russia

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2024 in Molecular Genetics, Microbiology and Virology
Verified
Journal Article
Closed access
PDF file
DRD. A. Rybal’CHenko
D. A. Rybal’CHenko
YLYu. V. Lozovsky
Yu. V. Lozovsky
YKYa. M. Krasnov
Ya. M. Krasnov
ESE. Yu. Shchelkanova
E. Yu. Shchelkanova
NSN. I. Smirnova
N. I. Smirnova
A comparative analysis of the genome of nontoxigenic and toxigenic V. cholerae O1 El Tor strains identified in Russia in 2023 and their phylogenetic analys

1 June 2026 in Molecular Genetics, Microbiology and Virology
Verified
Journal Article
Closed access
PDF file
SZS. P. Zadnova
S. P. Zadnova
DSD. A. Sergutin
D. A. Sergutin
NCN. B. Cheldyshova
N. B. Cheldyshova
ESE. Yu. Shchelkanova
E. Yu. Shchelkanova
AOA. V. Osin
A. V. Osin
NGN. E. Gaevskaya
N. E. Gaevskaya
The aim of this study was to analyze the CRISPR-Cas system of V. cholerae serogroup O1 strains of the classical biovar and nontoxigenic isolates of the El

14 January 2026 in Problems of Particularly Dangerous Infections
Verified
Journal Article
Closed access
GCG. V. Chekhovskaya
G. V. Chekhovskaya
IKI. M. Krepostnova
I. M. Krepostnova
DRD. A. Rybal’cHenko
D. A. Rybal’cHenko
ESE. Yu. Shchelkanova
E. Yu. Shchelkanova
NSN. I. Smirnova
N. I. Smirnova
The aim of the study was to obtain a cholera toxin B-subunit producer based on the avirulent probiotic strain Escherichia coli M-17 and to study its molecular-genetic and immunogenic properties. Materials and methods . The genetically marked E. coli KS164 thy polA (pIEM3) strain, containing a recombinant plasmid with the cloned ctxB gene encoding the B-subunit of cholera toxin, and the avirulent E. coli M-17 strain, applied for the production of colicontaining probiotics, were used. The strains were analyzed using various methods: molecular genetics, biochemistry, and immunology. Results and discussion . Through introducing the recombinant cointegrate plasmid pIEM3 (KmRTcR) with the cloned ctxB gene into E. coli M-17 cells via conjugation, KmRTcR transconjugants with high levels of secreted cholera toxin B-subunit production (10 μg/ml) were obtained. One of these transconjugants (KM147) was used as the producer strain for the protective antigen. It was demonstrated that the constructed E. coli strain KM147(pIEM3) KmRTcR stably inherits the cloned ctxB gene contained in the recombinant plasmid, is capable of producing antitoxic antibodies in immunized animals, and safe for the use in model animals. These properties combined make it promising for future use in the development of prophylactic and diagnostic cholera drugs.